Trademark: 77856081
Word
TOGENSIZ
Status
Dead
Status Code
606
Status Date
Monday, November 14, 2011
Serial Number
77856081
Mark Type
4000
Filing Date
Friday, October 23, 2009
Published for Opposition
Tuesday, August 17, 2010
Abandoned Date
Monday, November 14, 2011

Trademark Owner History
Bristol-Myers Squibb Company - Owner At Publication

Classifications
5 Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Trademark Events
Nov 14, 2011
Abandonment Notice Mailed - No Use Statement Filed
Nov 14, 2011
Abandonment - No Use Statement Filed
Apr 19, 2011
Attorney Revoked And/Or Appointed
Apr 19, 2011
Teas Revoke/Appoint Attorney Received
Mar 15, 2011
Notice Of Approval Of Extension Request Mailed
Mar 14, 2011
Extension 1 Granted
Mar 3, 2011
Extension 1 Filed
Mar 14, 2011
Case Assigned To Intent To Use Paralegal
Mar 3, 2011
Teas Extension Received
Oct 12, 2010
Noa Mailed - Sou Required From Applicant
Aug 17, 2010
Published For Opposition
Jul 28, 2010
Notice Of Publication
Jul 10, 2010
Law Office Publication Review Completed
Jul 10, 2010
Assigned To Lie
Jun 25, 2010
Approved For Pub - Principal Register
Jun 14, 2010
Teas/Email Correspondence Entered
Jun 14, 2010
Correspondence Received In Law Office
Jun 14, 2010
Teas Response To Office Action Received
Jan 29, 2010
Non-Final Action Mailed
Jan 29, 2010
Non-Final Action Written
Jan 28, 2010
Assigned To Examiner
Dec 28, 2009
Attorney Revoked And/Or Appointed
Dec 28, 2009
Teas Revoke/Appoint Attorney Received
Oct 28, 2009
New Application Office Supplied Data Entered In Tram
Oct 27, 2009
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24